A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
Clinical trial NCT05886777 · COMPLETED
Trial details
- NCT number
- NCT05886777
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2024-01-01
- Enrollment
- 1142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.